These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20819662)

  • 1. Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations.
    Ma YM; Li R; Qiao J; Zhang XW; Wang SY; Zhang QF; Li L; Tu BB; Zhang X
    Chin Med J (Engl); 2010 Aug; 123(16):2185-9. PubMed ID: 20819662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients.
    Strowitzki T; Capp E; von Eye Corleta H
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):178-81. PubMed ID: 20097466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gonadal function in young female affective illness associated with the menstrual cycle--in relation to the polycystic ovary syndrome].
    Matsunaga H; Sarai M; Taniguchi N; Kagomoto T; Inui M; Kameda H
    Seishin Shinkeigaku Zasshi; 1992; 94(8):738-58. PubMed ID: 1438600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome in adolescence.
    Blank SK; Helm KD; McCartney CR; Marshall JC
    Ann N Y Acad Sci; 2008; 1135():76-84. PubMed ID: 18574211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern.
    Prakansamut N; Sirayapiwat P; Triratanachat S
    J Med Assoc Thai; 2014 Feb; 97(2):159-64. PubMed ID: 24765893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine characteristics of polycystic ovary syndrome (PCOS).
    Szilágyi A; Szabó I
    Indian J Exp Biol; 2003 Jul; 41(7):694-700. PubMed ID: 15255372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
    March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
    Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
    Hart R; Hickey M; Franks S
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive adaptations to a large-brained fetus open a vulnerability to anovulation similar to polycystic ovary syndrome.
    Barnett DK; Abbott DH
    Am J Hum Biol; 2003; 15(3):296-319. PubMed ID: 12704707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reproductive phenotype in polycystic ovary syndrome.
    Chang RJ
    Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):688-95. PubMed ID: 17893687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome.
    Mozzanega B; Mioni R; Granzotto M; Chiarelli S; Xamin N; Zuliani L; Sicolo N; Marchesoni D; Vettor R
    Ann N Y Acad Sci; 2004 Dec; 1034():364-74. PubMed ID: 15731326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Different types of menstrual cycle and their significance in Chinese women diagnosed with polycystic ovary syndrome according to the Rotterdam consensus criteria].
    Xu XH; Tan YC; Shi YH; Wang B; Ju XQ; Zheng QM; Hao CF; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2604-6. PubMed ID: 20137675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome.
    Siow Y; Kives S; Hertweck P; Perlman S; Fallat ME
    Fertil Steril; 2005 Oct; 84(4):938-44. PubMed ID: 16213847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR; Eagleson CA; Marshall JC
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCOS in adolescents.
    Diamanti-Kandarakis E
    Best Pract Res Clin Obstet Gynaecol; 2010 Apr; 24(2):173-83. PubMed ID: 19932060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polycystic ovary syndrome].
    Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):298-301. PubMed ID: 10804375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive dysfunction in women with epilepsy: menstrual cycle abnormalities, fertility, and polycystic ovary syndrome.
    Bauer J; Cooper-Mahkorn D
    Int Rev Neurobiol; 2008; 83():135-55. PubMed ID: 18929079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.